News

Cantech Letter2h
Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis
In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV1 and superior in reducing sweat chloride compared to ...
Investing Snacks9h
Hold That Thought: Vertex Stays Steady Amidst Uncertainty
Morgan Stanley's analyst, Terence Flynn, sticks to his guns with a Hold rating for Vertex Pharmaceuticals, pegging the price ...